Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
INBX	Inhibrx Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.30M	-$140.06M	n/m	n/m	550.0%	-$9.04
INKT	MiNK Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.49M	n/a	n/a	n/a	-$2.93
INMB	Inmune Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.0K	-$45.93M	n/m	-195.3%	257.1%	-$1.86
INTS	Intensity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.61M	n/a	-97.7%	n/a	-$8.56
IOVA	Iovance Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$263.50M	-$390.98M	-148.4%	-56.0%	60.6%	-$1.09
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
JSPR	Jasper Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.80M	n/a	n/m	n/a	-$3.95
KLRS	Kalaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$43.44M	n/a	-55.1%	n/a	-$2.85
KOD	Kodiak Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$229.97M	n/a	-146.1%	n/a	-$4.32
KRYS	Krystal Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$389.13M	$204.83M	52.6%	16.8%	33.9%	$6.84
KYMR	Kymera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$39.21M	-$311.35M	-794.0%	-19.7%	-16.7%	-$3.69
KYTX	Kyverna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.31M	n/a	-69.4%	n/a	-$3.64
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
LENZ	LENZ Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$19.09M	-$82.13M	-430.3%	-28.9%	n/a	-$2.85
LIMN	Liminatus Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.21M	n/a	n/a	n/a	-$0.43
LONA	LeonaBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.61M	n/a	-380.0%	n/a	-$24.70
LXEO	Lexeo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$99.96M	n/a	-40.5%	n/a	-$1.86
MAZE	Maze Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$131.12M	n/a	-36.9%	n/a	-$3.05
MGTX	MeiraGTx Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$81.39M	-$114.20M	-140.3%	n/a	144.6%	-$1.42
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
MRNA	Moderna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.94B	-$2.82B	-145.2%	-32.6%	-39.9%	-$7.26
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
NMRA	Neumora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$236.93M	n/a	-228.1%	n/a	-$1.45
NVAX	Novavax Inc Manufacturing · Year ended 2025-12-31 · USD	$1.12B	$440.30M	39.2%	n/a	64.7%	$2.58

Rows per page: 2550 100